Showing results (331-340 of 824) with videos related to
Sort By:
Pageof 83
Experimental Hematology & Oncology|July 21, 2017
Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target eraLi Zhang, Yu-Tzu Tai, Matthew Zhi Guang Ho, et al.British Journal of Haematology|July 23, 2011
Monoclonal antibodies in the treatment of multiple myelomaPaul G Richardson, Sagar Lonial, Andrzej J Jakubowiak, et al.Nature Reviews. Clinical Oncology|July 3, 2024
Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteinsPaola Neri, Noémie Leblay, Holly Lee, et al.Seminars in Oncology|April 30, 2003
Novel biologically based therapies for Waldenstrom's macroglobulinemiaConstantine S Mitsiades, Nicholas Mitsiades, Paul G Richardson, et al.Journal of Leukocyte Biology|June 12, 2012
Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitorsSimone Cenci, Laura Oliva, Fulvia Cerruti, et al.Blood|August 30, 2003
Insights into the multistep transformation of MGUS to myeloma using microarray expression analysisFaith E Davies, Ann M Dring, Cheng Li, et al.British Journal of Haematology|October 28, 2017
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study resultsAndrew Spencer, Simon Harrison, Jeffrey Zonder, et al.European Journal of Cancer (Oxford, England : 1990)|June 13, 2006
The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactionsConstantine S Mitsiades, Nicholas S Mitsiades, Nikhil C Munshi, et al.Oral Oncology|August 22, 2008
Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patientsStephen T Sonis, Brynmor A Watkins, Gregory D Lyng, et al.Expert Opinion on Emerging Drugs|March 3, 2009
Emerging therapies for multiple myelomaKlaus Podar, Yu-Tzu Tai, Teru Hideshima, et al.Pageof 83